These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
820 related articles for article (PubMed ID: 27111338)
1. The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms. Chen Y; Fang F; Hu Y; Liu Q; Bu D; Tan M; Wu L; Zhu P PLoS One; 2016; 11(4):e0154183. PubMed ID: 27111338 [TBL] [Abstract][Full Text] [Related]
2. Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients. Macedo LC; de Cesare Quintero F; Pagliari-E-Silva S; Pagnano KB; Rodrigues C; de Alencar JB; Sell AM; Visentainer JE Blood Cells Mol Dis; 2016 Mar; 57():54-7. PubMed ID: 26852656 [TBL] [Abstract][Full Text] [Related]
3. Molecular genetic evaluation of myeloproliferative neoplasms. Azzato EM; Bagg A Int J Lab Hematol; 2015 May; 37 Suppl 1():61-71. PubMed ID: 25976962 [TBL] [Abstract][Full Text] [Related]
4. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis. Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600 [TBL] [Abstract][Full Text] [Related]
5. [Variation of LNK Gene in Chronic Myeloid Leukemia]. Tan M; Rong Y; Tian RM; Zhu YH; Zhu P; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):706-710. PubMed ID: 28641622 [TBL] [Abstract][Full Text] [Related]
6. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations. Turakhia SK; Murugesan G; Cotta CV; Theil KS J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830 [TBL] [Abstract][Full Text] [Related]
7. [The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms]. Lyu XD; Li YW; Guo Z; Xin YP; Hu JY; Fan RH; Song YP Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):35-39. PubMed ID: 31887834 [No Abstract] [Full Text] [Related]
8. MOLECULAR GENETIC ABNORMALITIES IN THE GENOME OF PATIENTS WITH Ph-NEGATIVE MYELOPROLIFERATIVE NEOPLASIA AFFECTED BY IONIZING RADIATION AS A RESULT OF THE CHORNOBYL NUCLEAR ACCIDENT. Poluben LO; Neumerzhytska LV; Klymenko SV; Fraenkel P; Balk C; Shumeiko OO Probl Radiac Med Radiobiol; 2020 Dec; 25():362-373. PubMed ID: 33361847 [TBL] [Abstract][Full Text] [Related]
9. Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing. Gardner JA; Peterson JD; Turner SA; Soares BL; Lancor CR; Dos Santos LL; Kaur P; Ornstein DL; Tsongalis GJ; de Abreu FB Am J Clin Pathol; 2016 Oct; 146(4):448-55. PubMed ID: 27686171 [TBL] [Abstract][Full Text] [Related]
10. A case of double positive myeloproliferative neoplasm: A diagnostic and therapeutic challenge. Shaikh AB; Aribandi A; Gupta A; Subramanian SK; Goyal M Indian J Pathol Microbiol; 2021; 64(4):820-823. PubMed ID: 34673614 [TBL] [Abstract][Full Text] [Related]
11. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype. Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178 [TBL] [Abstract][Full Text] [Related]
12. Rare Case of Accelerated-Phase Chronic Myeloid Leukemia Diagnosed During Treatment for JAK2 V617F-Positive Primary Myelofibrosis. Ryu J; Chu D; Park B; Kim M; Cho YU; Hwang SH; Jang S; Seo EJ; Lee JH; Park CJ Lab Med; 2022 Nov; 53(6):e140-e144. PubMed ID: 35243502 [TBL] [Abstract][Full Text] [Related]
13. Correlations between Janus kinase 2 V617F allele burdens and clinicohematologic parameters in myeloproliferative neoplasms. Ha JS; Kim YK; Jung SI; Jung HR; Chung IS Ann Lab Med; 2012 Nov; 32(6):385-91. PubMed ID: 23130336 [TBL] [Abstract][Full Text] [Related]
14. [JAK2 V617F and exon 12 genetic variations in Korean patients with BCR/ABL1-negative myeloproliferative neoplasms]. Kim JT; Cho YG; Choi SI; Lee YJ; Kim HR; Jang SJ; Moon DS; Park YJ; Park G Korean J Lab Med; 2010 Dec; 30(6):567-74. PubMed ID: 21157140 [TBL] [Abstract][Full Text] [Related]
15. Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications. Malak S; Labopin M; Saint-Martin C; Bellanne-Chantelot C; Najman A; Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):170-6. PubMed ID: 22818858 [TBL] [Abstract][Full Text] [Related]
16. Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosis. Moura LG; Tognon R; Nunes NS; Rodrigues LC; Ferreira AF; Kashima S; Covas DT; Santana M; Souto EX; Perobelli L; Simões BP; Dias-Baruffi M; Castro FA J Clin Pathol; 2016 Oct; 69(10):926-9. PubMed ID: 27402956 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of Clinical Characteristics of JAK2 V617F and BCR-ABL Double-Mutant Myeloproliferative Neoplasms]. Yan J; Ding YW; Wang PY; Wu YP; Zhang HC; Liu LH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1540-1547. PubMed ID: 34627437 [TBL] [Abstract][Full Text] [Related]
18. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond. Michiels JJ; Berneman Z; Schroyens W; De Raeve H Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India. Rabade N; Subramanian PG; Kodgule R; Raval G; Joshi S; Chaudhary S; Mascarenhas R; Tembhare P; Gujral S; Patkar N Indian J Pathol Microbiol; 2018; 61(2):209-213. PubMed ID: 29676359 [TBL] [Abstract][Full Text] [Related]
20. JAK2-V617F-mutated myeloproliferative neoplasms reveal different allele burden within hematopoietic cell lineages: a microdissection study of bone marrow trephine biopsies. Kreft A; Kindler T; Springer E; Kirkpatrick CJ Virchows Arch; 2011 Nov; 459(5):521-7. PubMed ID: 22006129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]